Quotient Investors’s Pfizer PFE Stock Holding History

Quotient Investors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$1.4M	Sell	41,420 -8,748	-17%	-$281K	0.96%	34
2017 Q2	$1.6M	Buy	50,168 +12,121	+32%	+$382K	1.14%	29
2017 Q1	$1.24M	Buy	38,047 +19,604	+106%	+$618K	0.74%	46
2016 Q4	$568K	Hold	18,443	–	–	0.36%	95
2016 Q3	$593K	Sell	18,443 -34,634	-65%	-$1.16M	0.38%	96
2016 Q2	$1.77M	Sell	53,077 -7,687	-13%	-$245K	0.84%	40
2016 Q1	$1.71M	Sell	60,764 -16,789	-22%	-$480K	0.63%	56
2015 Q4	$2.38M	Buy	77,553 +15,578	+25%	+$490K	0.91%	34
2015 Q3	$1.85M	Sell	61,975 -51,646	-45%	-$1.66M	0.41%	64
2015 Q2	$3.62M	Hold	113,621	–	–	0.49%	57
2015 Q1	$3.75M	Hold	113,621	–	–	0.51%	57
2014 Q4	$3.36M	Sell	113,621 -47,325	-29%	-$1.36M	0.69%	44
2014 Q3	$4.51M	Buy	160,946 +113,200	+237%	+$3.18M	0.99%	24
2014 Q2	$1.34M	Hold	47,746	–	–	0.29%	109
2014 Q1	$1.46M	Buy	47,746 +4,005	+9%	+$119K	0.33%	100
2013 Q4	$1.27M	Hold	43,741	–	–	0.3%	110
2013 Q3	$1.19M	Buy	43,741 +30,144	+222%	+$820K	0.31%	117
2013 Q2	$361K	Buy	+13,597	New	+$376K	0.1%	189

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Quotient Investors's PFE Position: Q3 2017 in Review

Quotient Investors reduced its Pfizer (PFE) stake by 17% in Q3 2017, selling an estimated $281K and leaving 41,420 shares worth $1.4M. The position accounts for 0.96% of the portfolio, ranked #34.

Quotient Investors first reported a position in PFE in Q2 2013 and has held it in 18 quarters since. The position peaked at $4.51M in Q3 2014. 2,041 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

Quotient Investors held 41,420 shares of Pfizer worth $1.4M as of Q3 2017.
Quotient Investors sold 8,748 Pfizer shares in Q3 2017, an estimated $281K.
Pfizer made up 0.96% of Quotient Investors's portfolio in Q3 2017, its #34 holding.
Quotient Investors first reported a position in Pfizer in Q2 2013 and has held it in 18 quarters since.
Quotient Investors's Pfizer position peaked at $4.51M in Q3 2014.
2,041 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Quotient Investors's 13F filing for Q3 2017, filed 18 Oct 2017.